Skip to main content

Table 5 Systemic inflammation

From: Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial

Test

Group

Pre-test

Post-test

Percent Change

p-value

Mean

+/− SD

Mean

+/− SD

IL-6

DTLT

0.84

0.54

0.67

0.27

−20%

= 0.038

SLT

0.71

0.11

0.65

0.13

−8%

= 0.037

MCP-1

DTLT

4.91

1.59

4.10

1.25

−7%

= 0.037

SLT

4.34

1.22

4.15

0.92

−4%

= 0.581

RANTES

DTLT

631.50

198.37

570.93

184.54

−10%

= 0.364

SLT

651.80

205.56

606.56

164.92

−7%

= 0.482

TNF-α

DTLT

0.44

0.06

0.49

0.11

+ 11%

= 0.099

SLT

0.44

0.07

0.47

0.12

+ 7%

= 0.285

  1. IL-6 interleukin-6, MCP-1 monocyte chemoattractant protein-1, RANTES regulated on activation, normally T-cell expressed and secreted, TNF-α tumour necrosis factor alpha